Insideraktier | 3 196 211 shares |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Nettoantalet insiders som köper (rankning)
N/A
Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).
Procent av flytande köpta av insiders (ranking)
N/A
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
CoLucid Pharmaceuticals, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
---|
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CLCD / CoLucid Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CLCD / CoLucid Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2017-03-01 | 2017-03-01 | 4 | LILLY ELI & CO | CLCD | Common Stock, par value $0.001 | D | 46,5000 | 19 285 108 | 896 758 | 100 | ||||
2017-03-01 | 2017-03-01 | 4 | PAPPAS ARTHUR M | CLCD | Stock Option (Right to Buy) | D | 6,24 | 40,2600 | −8 897 | −358 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | PAPPAS ARTHUR M | CLCD | Stock Option (Right to Buy) | D | 10,00 | 36,5000 | −5 954 | −217 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | PAPPAS ARTHUR M By Pappas Capital, LLC | CLCD | Common Stock | I | 46,5000 | −5 528 | −257 | 0 | ||||
2017-03-01 | 2017-03-01 | 4 | PAPPAS ARTHUR M By PV III CEO Fund, L.P. | CLCD | Common Stock | I | 46,5000 | −116 317 | −5 409 | 0 | ||||
2017-03-01 | 2017-03-01 | 4 | PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Common Stock | I | 46,5000 | −1 871 049 | −87 004 | 0 | ||||
2017-03-01 | 2017-03-01 | 4 | Skwierczynski Raymond | CLCD | Employee Stock Option (Right to Buy) | D | 6,75 | 39,7500 | −15 000 | −596 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Skwierczynski Raymond | CLCD | Employee Stock Option (Right to Buy) | D | 5,69 | 40,8100 | −90 000 | −3 673 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Skwierczynski Raymond | CLCD | Common Stock | D | 46,5000 | −3 615 | −168 | 0 | ||||
2017-03-01 | 2017-03-01 | 4 | White Marvin L | CLCD | Stock Option (Right to Buy) | D | 36,20 | 10,3000 | −453 | −5 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | White Marvin L | CLCD | Stock Option (Right to Buy) | D | 9,62 | 36,8800 | −1 630 | −60 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | White Marvin L | CLCD | Stock Option (Right to Buy) | D | 6,24 | 40,2600 | −8 897 | −358 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | White Marvin L | CLCD | Stock Option (Right to Buy) | D | 8,50 | 38,0000 | −997 | −38 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | White Marvin L | CLCD | Stock Option (Right to Buy) | D | 8,60 | 37,9000 | −6 577 | −249 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Mathers Thomas P. | CLCD | Restricted Stock Units | D | 46,5000 | −105 147 | −4 889 | 0 | ||||
2017-03-01 | 2017-03-01 | 4 | Mathers Thomas P. | CLCD | Employee Stock Option (Right to Buy) | D | 6,75 | 39,7500 | −83 000 | −3 299 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Mathers Thomas P. | CLCD | Employee Stock Option (Right to Buy) | D | 10,00 | 36,5000 | −360 508 | −13 159 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 46,5000 | −83 000 | −3 860 | 0 | ||||
2017-03-01 | 2017-03-01 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 46,5000 | −173 519 | −8 069 | 0 | ||||
2017-03-01 | 2017-03-01 | 4 | Lawton Alison Frances | CLCD | Stock Option (Right to Buy) | D | 36,20 | 10,3000 | −658 | −7 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Lawton Alison Frances | CLCD | Stock Option (Right to Buy) | D | 6,24 | 40,2600 | −8 897 | −358 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Lawton Alison Frances | CLCD | Stock Option (Right to Buy) | D | 6,54 | 39,9600 | −1 420 | −57 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Marengere Luc | CLCD | Stock Option (Right to Buy) | D | 36,20 | 10,3000 | −658 | −7 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Marengere Luc | CLCD | Stock Option (Right to Buy) | D | 9,62 | 36,8800 | −2 371 | −87 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Marengere Luc | CLCD | Stock Option (Right to Buy) | D | 6,24 | 40,2600 | −8 897 | −358 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Marengere Luc | CLCD | Stock Option (Right to Buy) | D | 8,50 | 38,0000 | −1 449 | −55 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Marengere Luc | CLCD | Stock Option (Right to Buy) | D | 10,00 | 36,5000 | −5 954 | −217 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Marengere Luc By TVM Life Science Ventures VII L.P. | CLCD | Common Stock | I | 46,5000 | −1 545 386 | −71 860 | 0 | ||||
2017-03-01 | 2017-03-01 | 4 | CORRIGAN MARK | CLCD | Stock Option (Right to Buy) | D | 6,24 | 40,2600 | −8 897 | −358 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | CORRIGAN MARK | CLCD | Stock Option (Right to Buy) | D | 3,79 | 42,7100 | −8 114 | −347 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Dallas Matthew D | CLCD | Employee Stock Option (Right to Buy) | D | 6,75 | 39,7500 | −37 500 | −1 491 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Dallas Matthew D | CLCD | Employee Stock Option (Right to Buy) | D | 7,56 | 38,9400 | −30 000 | −1 168 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Dallas Matthew D | CLCD | Employee Stock Option (Right to Buy) | D | 10,00 | 36,5000 | −180 254 | −6 579 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Dallas Matthew D | CLCD | Common Stock | D | 46,5000 | −37 500 | −1 744 | 0 | ||||
2017-03-01 | 2017-03-01 | 4 | Dallas Matthew D | CLCD | Common Stock | D | 46,5000 | −2 708 | −126 | 0 | ||||
2017-03-01 | 2017-03-01 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 6,75 | 39,7500 | −26 594 | −1 057 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 7,56 | 38,9400 | −5 741 | −224 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 10,00 | 36,5000 | −46 966 | −1 714 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Kuca Bernice | CLCD | Employee Stock Option (right to buy) | D | 6,75 | 39,7500 | −37 500 | −1 491 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Kuca Bernice | CLCD | Employee Stock Option (right to buy) | D | 10,00 | 36,5000 | −270 381 | −9 869 | 0 | |||
2017-03-01 | 2017-03-01 | 4 | Kuca Bernice | CLCD | Common Stock | D | 46,5000 | −37 500 | −1 744 | 0 | ||||
2017-03-01 | 2017-03-01 | 4 | Kuca Bernice | CLCD | Common Stock | D | 46,5000 | −2 729 | −127 | 0 | ||||
2017-01-27 | 3 | ProCar Acquisition Corp | CLCD | Common stock | D | 109 366 | ||||||||
2017-01-27 | 3 | ProCar Acquisition Corp | CLCD | Common stock | D | 109 366 | ||||||||
2017-01-27 | 3 | ProCar Acquisition Corp | CLCD | Common stock | D | 109 366 | ||||||||
2017-01-05 | 2017-01-05 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 10,00 | −1 677 | 46 966 | |||||
2017-01-05 | 2017-01-05 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 35,6083 | −600 | −21 | 0 | ||||
2017-01-05 | 2017-01-05 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 34,4000 | −600 | −21 | 600 | ||||
2017-01-05 | 2017-01-05 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 33,5548 | −477 | −16 | 1 200 | ||||
2017-01-05 | 2017-01-05 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 10,0000 | 1 677 | 17 | 1 677 | ||||
2017-01-05 | 2017-01-04 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 7,56 | −185 | 5 741 | |||||
2017-01-05 | 2017-01-04 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 36,4000 | −185 | −7 | 0 | ||||
2017-01-05 | 2017-01-04 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 7,5600 | 185 | 1 | 185 | ||||
2017-01-05 | 2017-01-03 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 6,75 | −718 | 26 594 | |||||
2017-01-05 | 2017-01-03 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 36,2500 | −718 | −26 | 0 | ||||
2017-01-05 | 2017-01-03 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 6,7500 | 718 | 5 | 718 | ||||
2017-01-05 | 2017-01-05 | 4 | Mathers Thomas P. | CLCD | Restricted Stock Units | D | −3 755 | 105 147 | ||||||
2017-01-05 | 2017-01-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 35,6000 | −500 | −18 | 256 519 | ||||
2017-01-05 | 2017-01-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 34,8625 | −200 | −7 | 257 019 | ||||
2017-01-05 | 2017-01-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 34,2462 | −802 | −27 | 257 219 | ||||
2017-01-05 | 2017-01-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 3 755 | 258 021 | ||||||
2017-01-04 | 2017-01-03 | 4 | White Marvin L | CLCD | Stock Option (Right to Buy) | D | 36,20 | 30,3500 | 453 | 14 | 453 | |||
2017-01-04 | 2017-01-03 | 4 | Lawton Alison Frances | CLCD | Stock Option (Right to Buy) | D | 36,20 | 30,4000 | 658 | 20 | 658 | |||
2017-01-04 | 2017-01-03 | 4 | Dallas Matthew D | CLCD | Common Stock | D | 36,2500 | −1 473 | −53 | 40 128 | ||||
2017-01-04 | 2017-01-03 | 4 | Marengere Luc | CLCD | Stock Option (Right to Buy) | D | 36,20 | 30,4000 | 658 | 20 | 658 | |||
2017-01-04 | 2017-01-03 | 4 | Kuca Bernice | CLCD | Common Stock | D | 36,2500 | −772 | −28 | 40 086 | ||||
2016-12-05 | 2016-12-05 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 10,00 | −1 678 | 48 643 | |||||
2016-12-05 | 2016-12-05 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 7,56 | −186 | 5 926 | |||||
2016-12-05 | 2016-12-05 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 38,7500 | −1 678 | −65 | 0 | ||||
2016-12-05 | 2016-12-05 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 10,0000 | 1 678 | 17 | 1 678 | ||||
2016-12-05 | 2016-12-05 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 38,7500 | −186 | −7 | 0 | ||||
2016-12-05 | 2016-12-05 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 7,5600 | 186 | 1 | 186 | ||||
2016-12-05 | 2016-12-01 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 6,75 | −719 | 27 312 | |||||
2016-12-05 | 2016-12-01 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 35,2191 | −719 | −25 | 0 | ||||
2016-12-05 | 2016-12-01 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 6,7500 | 719 | 5 | 719 | ||||
2016-12-05 | 2016-12-05 | 4 | Mathers Thomas P. | CLCD | Restricted Stock Units | D | −3 756 | 108 902 | ||||||
2016-12-05 | 2016-12-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 38,7500 | −1 502 | −58 | 254 266 | ||||
2016-12-05 | 2016-12-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 3 756 | 255 768 | ||||||
2016-12-01 | 2016-12-01 | 4 | Dallas Matthew D | CLCD | Common Stock | D | 35,1671 | −1 473 | −52 | 41 601 | ||||
2016-12-01 | 2016-12-01 | 4 | Kuca Bernice | CLCD | Common Stock | D | 35,2202 | −772 | −27 | 40 858 | ||||
2016-11-07 | 2016-11-07 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 10,00 | −1 677 | 50 321 | |||||
2016-11-07 | 2016-11-07 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 28,5212 | −1 677 | −48 | 0 | ||||
2016-11-07 | 2016-11-07 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 10,0000 | 1 677 | 17 | 1 677 | ||||
2016-11-07 | 2016-11-04 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 7,56 | −185 | 6 112 | |||||
2016-11-07 | 2016-11-04 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 28,9500 | −185 | −5 | 0 | ||||
2016-11-07 | 2016-11-04 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 7,5600 | 185 | 1 | 185 | ||||
2016-11-07 | 2016-11-07 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 28,5732 | −1 502 | −43 | 248 920 | ||||
2016-11-07 | 2016-11-05 | 4 | Mathers Thomas P. | CLCD | Restricted Stock Units | D | −3 755 | 112 658 | ||||||
2016-11-07 | 2016-11-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 3 755 | 250 422 | ||||||
2016-11-01 | 2016-11-01 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 6,75 | −719 | 28 031 | |||||
2016-11-01 | 2016-11-01 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 30,0000 | −719 | −22 | 0 | ||||
2016-11-01 | 2016-11-01 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 6,7500 | 719 | 5 | 719 | ||||
2016-10-05 | 2016-10-05 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 10,00 | −1 677 | 51 998 | |||||
2016-10-05 | 2016-10-05 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 37,0800 | −1 677 | −62 | 0 | ||||
2016-10-05 | 2016-10-05 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 10,0000 | 1 677 | 17 | 1 677 | ||||
2016-10-05 | 2016-10-04 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 7,56 | −185 | 6 297 | |||||
2016-10-05 | 2016-10-04 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 36,4100 | −185 | −7 | 0 | ||||
2016-10-05 | 2016-10-04 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 7,5600 | 185 | 1 | 185 | ||||
2016-10-05 | 2016-10-03 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 6,75 | −719 | 28 750 | |||||
2016-10-05 | 2016-10-03 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 37,7400 | −719 | −27 | 0 | ||||
2016-10-05 | 2016-10-03 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 6,7500 | 719 | 5 | 719 | ||||
2016-10-05 | 2016-10-05 | 4 | Mathers Thomas P. | CLCD | Restricted Stock Units | D | −3 755 | 116 413 | ||||||
2016-10-05 | 2016-10-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 37,0800 | −1 502 | −56 | 246 667 | ||||
2016-10-05 | 2016-10-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 3 755 | 248 169 | ||||||
2016-09-16 | 2016-09-14 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 23,7800 | −300 | −7 | 244 414 | ||||
2016-09-16 | 2016-09-14 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 23,3004 | −5 700 | −133 | 244 714 | ||||
2016-09-13 | 2016-09-09 | 4 | Domain Partners VI, L.P. | CLCD | Common Stock | D | −1 943 109 | 0 | ||||||
2016-09-13 | 2016-09-09 | 4 | Novo A/S | CLCD | COMMON STOCK | D | 20,0000 | 100 000 | 2 000 | 3 156 563 | ||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. By LLH Associates, LLC | CLCD | Stock Option (Right to Buy) | I | 5,09 | −896 | 0 | |||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. By LLH Associates, LLC | CLCD | Stock Option (Right to Buy) | I | 5,09 | −2 839 | 0 | |||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 6,75 | −5 031 | 29 469 | |||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 7,56 | −3 518 | 6 482 | |||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 10,00 | −36 452 | 53 675 | |||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. By LLH Associates, LLC | CLCD | Common Stock | I | 19,5000 | −3 735 | −73 | 0 | ||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. By LLH Associates, LLC | CLCD | Common Stock | I | 5,0900 | 896 | 5 | 3 735 | ||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. By LLH Associates, LLC | CLCD | Common Stock | I | 5,0900 | 2 839 | 14 | 2 839 | ||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 20,0011 | −31 420 | −628 | 0 | ||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 20,0000 | −5 032 | −101 | 31 420 | ||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 19,5000 | −8 549 | −167 | 36 452 | ||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 6,7500 | 5 031 | 34 | 45 001 | ||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 7,5600 | 3 518 | 27 | 39 970 | ||||
2016-09-07 | 2016-09-06 | 4 | Hogan Linda C. | CLCD | Common Stock | D | 10,0000 | 36 452 | 365 | 36 452 | ||||
2016-09-07 | 2016-09-07 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 24,3967 | −300 | −7 | 250 414 | ||||
2016-09-07 | 2016-09-07 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 23,4267 | −442 | −10 | 250 714 | ||||
2016-09-07 | 2016-09-07 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 22,6164 | −2 633 | −60 | 251 156 | ||||
2016-09-07 | 2016-09-07 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 21,9045 | −962 | −21 | 253 789 | ||||
2016-09-07 | 2016-09-07 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 20,5555 | −663 | −14 | 254 751 | ||||
2016-09-07 | 2016-09-06 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 19,5000 | −1 502 | −29 | 255 414 | ||||
2016-09-07 | 2016-09-05 | 4 | Mathers Thomas P. | CLCD | Restricted Stock Units | D | −3 756 | 120 168 | ||||||
2016-09-07 | 2016-09-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 3 756 | 256 916 | ||||||
2016-08-31 | 2016-08-31 | 4 | Skwierczynski Raymond | CLCD | Common Stock | D | 10,8600 | −150 | −2 | 47 | ||||
2016-08-19 | 2016-08-19 | 4 | Skwierczynski Raymond | CLCD | Common Stock | D | 8,4100 | −508 | −4 | 197 | ||||
2016-08-10 | 2016-08-10 | 4 | Skwierczynski Raymond | CLCD | Common Stock | D | 8,3000 | −508 | −4 | 705 | ||||
2016-08-05 | 2016-08-05 | 4 | Mathers Thomas P. | CLCD | Restricted Stock Units | D | −3 755 | 123 924 | ||||||
2016-08-05 | 2016-08-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 8,3100 | −1 502 | −12 | 253 160 | ||||
2016-08-05 | 2016-08-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 3 755 | 254 662 | ||||||
2016-08-03 | 2016-08-03 | 4 | Domain Partners VI, L.P. | CLCD | Common Stock | D | 8,1500 | −81 094 | −661 | 1 943 109 | ||||
2016-08-03 | 2016-08-02 | 4 | Domain Partners VI, L.P. | CLCD | Common Stock | D | 8,7100 | −19 718 | −172 | 2 024 203 | ||||
2016-08-03 | 2016-08-01 | 4 | Domain Partners VI, L.P. | CLCD | Common Stock | D | 8,8200 | −52 216 | −461 | 2 043 921 | ||||
2016-08-03 | 2016-08-03 | 4 | DP VI Associates, L.P. | CLCD | Common Stock | D | 8,1500 | −129 | −1 | 3 039 | ||||
2016-08-03 | 2016-08-02 | 4 | DP VI Associates, L.P. | CLCD | Common Stock | D | 8,7100 | −32 | −0 | 3 168 | ||||
2016-08-03 | 2016-08-01 | 4 | DP VI Associates, L.P. | CLCD | Common Stock | D | 8,8200 | −84 | −1 | 3 200 | ||||
2016-07-29 | 2016-07-29 | 4 | Skwierczynski Raymond | CLCD | Common Stock | D | 9,0850 | −508 | −5 | 1 213 | ||||
2016-07-20 | 2016-07-20 | 4 | Skwierczynski Raymond | CLCD | Common Stock | D | 8,9700 | −508 | −5 | 1 721 | ||||
2016-07-12 | 2016-07-11 | 4 | Skwierczynski Raymond | CLCD | Common Stock | D | 9,1000 | −508 | −5 | 2 229 | ||||
2016-07-05 | 2016-07-01 | 4 | White Marvin L | CLCD | Stock Option (Right to Buy) | D | 9,62 | 8,4400 | 1 630 | 14 | 1 630 | |||
2016-07-05 | 2016-07-01 | 4 | Marengere Luc | CLCD | Stock Option (Right to Buy) | D | 9,62 | 8,4400 | 2 371 | 20 | 2 371 | |||
2016-07-05 | 2016-07-05 | 4 | Mathers Thomas P. | CLCD | Restricted Stock Units | D | −3 755 | 127 679 | ||||||
2016-07-05 | 2016-07-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 9,7300 | −1 502 | −15 | 250 907 | ||||
2016-07-05 | 2016-07-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 3 755 | 252 409 | ||||||
2016-06-30 | 2016-06-30 | 4 | Skwierczynski Raymond | CLCD | Common Stock | D | 7,0110 | −516 | −4 | 2 737 | ||||
2016-06-22 | 2016-06-20 | 4 | Skwierczynski Raymond | CLCD | Common Stock | D | 7,0000 | −500 | −4 | 3 253 | ||||
2016-06-22 | 2016-06-10 | 4 | Skwierczynski Raymond | CLCD | Common Stock | D | 6,5984 | −508 | −3 | 3 753 | ||||
2016-06-07 | 2016-06-06 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 7,2463 | −1 502 | −11 | 248 654 | ||||
2016-06-07 | 2016-06-05 | 4 | Mathers Thomas P. | CLCD | Restricted Stock Units | D | −3 756 | 131 434 | ||||||
2016-06-07 | 2016-06-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 3 756 | 250 156 | ||||||
2016-05-12 | 2016-05-10 | 4 | CORRIGAN MARK | CLCD | Stock Option (Right to Buy) | D | 6,24 | 8 897 | 8 897 | |||||
2016-05-12 | 2016-05-10 | 4 | PAPPAS ARTHUR M | CLCD | Stock Option (Right to Buy) | D | 6,24 | 8 897 | 8 897 | |||||
2016-05-12 | 2016-05-10 | 4 | White Marvin L | CLCD | Stock Option (Right to Buy) | D | 6,24 | 8 897 | 8 897 | |||||
2016-05-12 | 2016-05-10 | 4 | Lawton Alison Frances | CLCD | Stock Option (Right to Buy) | D | 6,24 | 8 897 | 8 897 | |||||
2016-05-12 | 2016-05-10 | 4 | Marengere Luc | CLCD | Stock Option (Right to Buy) | D | 6,24 | 8 897 | 8 897 | |||||
2016-05-09 | 2016-05-05 | 4 | Mathers Thomas P. | CLCD | Restricted Stock Units | D | −45 064 | 135 190 | ||||||
2016-05-09 | 2016-05-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 6,4900 | −14 624 | −95 | 241 400 | ||||
2016-05-09 | 2016-05-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 45 064 | 256 024 | ||||||
2016-05-02 | 2016-04-28 | 4 | DP VI Associates, L.P. | CLCD | Common Stock | D | 6,9600 | −235 | −2 | 3 284 | ||||
2016-05-02 | 2016-04-28 | 4 | Domain Partners VI, L.P. | CLCD | Common Stock | D | 6,9600 | −149 765 | −1 042 | 2 096 137 | ||||
2016-03-15 | 2016-03-11 | 4 | Lawton Alison Frances | CLCD | Stock Option (Right to Buy) | D | 6,54 | 1 420 | 1 420 | |||||
2016-03-07 | 2016-03-04 | 4 | Dallas Matthew D | CLCD | Employee Stock Option (Right to Buy) | D | 6,75 | 37 500 | 37 500 | |||||
2016-03-07 | 2016-03-04 | 4 | Dallas Matthew D | CLCD | Common Stock | D | 37 500 | 37 500 | ||||||
2016-03-07 | 2016-03-04 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 6,75 | 34 500 | 34 500 | |||||
2016-03-07 | 2016-03-04 | 4 | Kuca Bernice | CLCD | Employee Stock Option (Right to Buy) | D | 6,75 | 37 500 | 37 500 | |||||
2016-03-07 | 2016-03-04 | 4 | Kuca Bernice | CLCD | Common Stock | D | 37 500 | 37 500 | ||||||
2016-03-07 | 2016-03-04 | 4 | Mathers Thomas P. | CLCD | Employee Stock Option (Right to Buy) | D | 6,75 | 83 000 | 83 000 | |||||
2016-03-07 | 2016-03-04 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 83 000 | 210 960 | ||||||
2016-03-07 | 2016-03-04 | 4 | Skwierczynski Raymond | CLCD | Employee Stock Option (Right to Buy) | D | 6,75 | 15 000 | 15 000 | |||||
2016-01-06 | 2016-01-04 | 4 | White Marvin L | CLCD | Stock Option (Right to Buy) | D | 8,50 | 6,9000 | 997 | 7 | 997 | |||
2016-01-06 | 2016-01-04 | 4 | Marengere Luc | CLCD | Stock Option (Right to Buy) | D | 8,50 | 6,9000 | 1 449 | 10 | 1 449 | |||
2015-12-02 | 2015-11-30 | 4 | Skwierczynski Raymond | CLCD | Employee Stock Option (Right to Buy) | D | 5,69 | 90 000 | 90 000 | |||||
2015-11-06 | 2015-11-05 | 4 | Mathers Thomas P. | CLCD | Restricted Stock Units | D | −180 254 | 180 254 | ||||||
2015-11-06 | 2015-11-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 4,5800 | −59 794 | −274 | 127 960 | ||||
2015-11-06 | 2015-11-05 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 180 254 | 187 754 | ||||||
2015-10-29 | 2015-10-27 | 4 | CORRIGAN MARK | CLCD | Stock Option (Right to Buy) | D | 3,79 | 8 114 | 8 114 | |||||
2015-08-25 | 2015-08-25 | 4 | Mathers Thomas P. | CLCD | Common Stock | D | 7,1033 | 7 500 | 53 | 7 500 | ||||
2015-08-06 | 2015-08-04 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 7,56 | 10 000 | 10 000 | |||||
2015-08-06 | 2015-08-04 | 4 | Dallas Matthew D | CLCD | Employee Stock Option (Right to Buy) | D | 7,56 | 30 000 | 30 000 | |||||
2015-07-13 | 2015-07-09 | 4 | White Marvin L | CLCD | Stock Option (Right to Buy) | D | 8,60 | 6 577 | 6 577 | |||||
2015-05-13 | 2015-05-13 | 4 | Rupniak Nadia | CLCD | Employee Stock Option (Right to Buy) | D | 5,09 | −3 690 | 0 | |||||
2015-05-13 | 2015-05-13 | 4 | Rupniak Nadia | CLCD | Employee Stock Option (Right to Buy) | D | 5,09 | −5 541 | 0 | |||||
2015-05-13 | 2015-05-13 | 4 | Rupniak Nadia | CLCD | Employee Stock Option (Right to Buy) | D | 4,07 | −2 457 | 0 | |||||
2015-05-13 | 2015-05-13 | 4 | Rupniak Nadia | CLCD | Employee Stock Option (Right to Buy) | D | 4,07 | −2 457 | 0 | |||||
2015-05-13 | 2015-05-13 | 4 | Rupniak Nadia | CLCD | Common Stock | D | 5,0900 | 3 690 | 19 | 14 145 | ||||
2015-05-13 | 2015-05-13 | 4 | Rupniak Nadia | CLCD | Common Stock | D | 5,0900 | 5 541 | 28 | 10 455 | ||||
2015-05-13 | 2015-05-13 | 4 | Rupniak Nadia | CLCD | Common Stock | D | 4,0700 | 2 457 | 10 | 4 914 | ||||
2015-05-13 | 2015-05-13 | 4 | Rupniak Nadia | CLCD | Common Stock | D | 4,0700 | 2 457 | 10 | 4 914 | ||||
2015-05-12 | 2015-05-11 | 4 | Novo A/S | CLCD | SERIES C PREFERRED STOCK | D | −1 756 563 | 0 | ||||||
2015-05-12 | 2015-05-11 | 4 | Novo A/S | CLCD | COMMON STOCK | D | 10,0000 | 1 300 000 | 13 000 | 3 056 563 | ||||
2015-05-12 | 2015-05-11 | 4 | Novo A/S | CLCD | COMMON STOCK | D | 1 756 563 | 1 756 563 | ||||||
2015-05-12 | 2015-05-11 | 4 | PAPPAS ARTHUR M By PV III CEO Fund, L.P. | CLCD | Series C Convertible Preferred Stock | I | −20 808 | 0 | ||||||
2015-05-12 | 2015-05-11 | 4 | PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Series C Convertible Preferred Stock | I | −334 722 | 0 | ||||||
2015-05-12 | 2015-05-11 | 4 | PAPPAS ARTHUR M By PV III CEO Fund, L.P. | CLCD | Series B Convertible Preferred Stock | I | −41 996 | 0 | ||||||
2015-05-12 | 2015-05-11 | 4 | PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Series B Convertible Preferred Stock | I | −675 588 | 0 | ||||||
2015-05-12 | 2015-05-11 | 4 | PAPPAS ARTHUR M By PV III CEO Fund, L.P. | CLCD | Series A Convertible Preferred Stock | I | −35 953 | 0 | ||||||
2015-05-12 | 2015-05-11 | 4 | PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Series A Convertible Preferred Stock | I | −578 297 | 0 | ||||||
2015-05-12 | 2015-05-11 | 4 | PAPPAS ARTHUR M By PV III CEO Fund, L.P. | CLCD | Common Stock | I | 10,0000 | 17 560 | 176 | 116 317 | ||||
2015-05-12 | 2015-05-11 | 4 | PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Common Stock | I | 10,0000 | 282 440 | 2 824 | 1 871 049 | ||||
2015-05-12 | 2015-05-11 | 4 | PAPPAS ARTHUR M By PV III CEO Fund, L.P. | CLCD | Common Stock | I | 98 757 | 98 757 | ||||||
2015-05-12 | 2015-05-11 | 4 | PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Common Stock | I | 1 588 607 | 1 588 609 | ||||||
2015-05-12 | 2015-05-11 | 4 | Markham Richard J By Care Capital Offshore Investments III, LP | CLCD | Series C Convertible Preferred Stock | I | −5 353 | 0 | ||||||
2015-05-12 | 2015-05-11 | 4 | Markham Richard J By Care Capital Investments III, LP | CLCD | Series C Convertible Preferred Stock | I | −320 295 | 0 | ||||||
2015-05-12 | 2015-05-11 | 4 | Markham Richard J By Care Capital Offshore Investments III, LP | CLCD | Series B Convertible Preferred Stock | I | −20 050 | 0 | ||||||
2015-05-12 | 2015-05-11 | 4 | Markham Richard J By Care Capital Investments III, LP | CLCD | Series B Convertible Preferred Stock | I | −1 199 841 | 0 | ||||||
2015-05-12 | 2015-05-11 | 4 | Markham Richard J By Care Capital Offshore Investments III, LP | CLCD | Common Stock | I | 25 403 | 25 403 | ||||||
2015-05-12 | 2015-05-11 | 4 | Markham Richard J By Care Capital Investments III, LP | CLCD | Common Stock | I | 1 520 136 | 1 520 136 | ||||||
2015-05-12 | 2015-05-11 | 4 | Marengere Luc By TVM Life Science Ventures VII L.P. | CLCD | Series C Convertible Preferred Stock | I | −995 386 | 0 | ||||||
2015-05-12 | 2015-05-11 | 4 | Marengere Luc By TVM Life Science Ventures VII L.P. | CLCD | Common Stock | I | 10,0000 | 500 000 | 5 000 | 1 495 386 | ||||
2015-05-12 | 2015-05-11 | 4 | Marengere Luc By TVM Life Science Ventures VII L.P. | CLCD | Common Stock | I | 995 386 | 995 386 | ||||||
2015-05-11 | 2015-05-11 | 4 | Domain Partners VI, L.P. | CLCD | Series C Preferred Stock | D | −464 756 | 0 | ||||||
2015-05-11 | 2015-05-11 | 4 | Domain Partners VI, L.P. | CLCD | Series B Preferred Stock | D | −939 289 | 0 | ||||||
2015-05-11 | 2015-05-11 | 4 | Domain Partners VI, L.P. | CLCD | Series A Preferred Stock | D | −798 188 | 0 | ||||||
2015-05-11 | 2015-05-11 | 4 | Domain Partners VI, L.P. | CLCD | Common Stock | D | 2 202 233 | 2 245 902 | ||||||
2015-05-11 | 2015-05-11 | 4 | DP VI Associates, L.P. | CLCD | Series B Preferred Stock | D | −1 565 | 0 | ||||||
2015-05-11 | 2015-05-11 | 4 | DP VI Associates, L.P. | CLCD | Series A Preferred Stock | D | −1 954 | 0 | ||||||
2015-05-11 | 2015-05-11 | 4 | DP VI Associates, L.P. | CLCD | Common Stock | D | 3 519 | 3 519 | ||||||
2015-05-07 | 2015-05-05 | 4 | TREU JESSE I | CLCD | Stock Option (Right to Buy) | D | 10,00 | 5 954 | 5 954 | |||||
2015-05-07 | 2015-05-05 | 4 | PAPPAS ARTHUR M | CLCD | Stock Option (Right to Buy) | D | 10,00 | 5 954 | 5 954 | |||||
2015-05-07 | 2015-03-23 | 4 | PAPPAS ARTHUR M By A.M. Pappas & Associates, LLC | CLCD | Stock Option (Right to Buy) | I | 4,07 | −5 528 | 0 | |||||
2015-05-07 | 2015-03-23 | 4 | PAPPAS ARTHUR M By A.M. Pappas & Associates, LLC | CLCD | Common Stock | I | 4,0700 | 5 528 | 22 | 5 528 | ||||
2015-05-07 | 2015-01-12 | 4 | PAPPAS ARTHUR M By PV III CEO Fund, L.P. | CLCD | Series C Convertible Preferred Stock | I | 20 808 | 20 808 | ||||||
2015-05-07 | 2015-01-12 | 4 | PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Series C Convertible Preferred Stock | I | 334 722 | 334 722 | ||||||
2015-05-07 | 2015-01-12 | 4 | PAPPAS ARTHUR M By PV III CEO Fund, L.P. | CLCD | Series B Convertible Preferred Stock | I | 33 597 | 33 597 | ||||||
2015-05-07 | 2015-01-12 | 4 | PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Series B Convertible Preferred Stock | I | 540 470 | 540 470 | ||||||
2015-05-07 | 2015-01-12 | 4 | PAPPAS ARTHUR M By PV III CEO Fund, L.P. | CLCD | Series A Convertible Preferred Stock | I | 28 763 | 28 763 | ||||||
2015-05-07 | 2015-01-12 | 4 | PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Series A Convertible Preferred Stock | I | 462 637 | 462 637 | ||||||
2015-05-07 | 2015-05-05 | 4 | Markham Richard J | CLCD | Stock Option (Right to Buy) | D | 10,00 | 5 954 | 5 954 | |||||
2015-05-07 | 2015-01-12 | 4 | Markham Richard J By Care Capital Offshore Investments III, LP | CLCD | Series C Convertible Preferred Stock | I | 5 353 | 5 353 | ||||||
2015-05-07 | 2015-01-12 | 4 | Markham Richard J By Care Capital Investments III, LP | CLCD | Series C Convertible Preferred Stock | I | 320 295 | 320 295 | ||||||
2015-05-07 | 2015-01-12 | 4 | Markham Richard J By Care Capital Offshore Investments III, LP | CLCD | Series B Convertible Preferred Stock | I | 16 041 | 16 041 | ||||||
2015-05-07 | 2015-01-12 | 4 | Markham Richard J By Care Capital Investments III, LP | CLCD | Series B Convertible Preferred Stock | I | 959 872 | 959 872 | ||||||
2015-05-07 | 2015-05-05 | 4 | Dallas Matthew D | CLCD | Employee Stock Option (Right to Buy) | D | 10,00 | 180 254 | 180 254 | |||||
2015-05-07 | 2015-05-05 | 4 | Hogan Linda C. | CLCD | Stock Option (Right to Buy) | D | 10,00 | 90 127 | 90 127 | |||||
2015-05-07 | 2015-05-05 | 4 | Rupniak Nadia | CLCD | Employee Stock Option (Right to Buy) | D | 10,00 | 135 190 | 135 190 | |||||
2015-05-07 | 2015-05-05 | 4 | Kuca Bernice | CLCD | Employee Stock Option (Right to Buy) | D | 10,00 | 270 381 | 270 381 | |||||
2015-05-07 | 2015-05-05 | 4 | Mathers Thomas P. | CLCD | Employee Stock Option (Right to Buy) | D | 10,00 | 360 508 | 360 508 | |||||
2015-05-07 | 2015-05-05 | 4 | Mathers Thomas P. | CLCD | Restricted Stock Units | D | 360 508 | 360 508 | ||||||
2015-05-07 | 2015-05-05 | 4 | Marengere Luc | CLCD | Stock Option (Right to Buy) | D | 10,00 | 5 954 | 5 954 | |||||
2015-05-07 | 2015-01-12 | 4 | Marengere Luc By TVM Life Science Ventures VII L.P. | CLCD | Series C Convertible Preferred Stock | I | 995 386 | 995 386 | ||||||
2015-05-05 | 3 | VITULLO NICOLE | CLCD | Common Stock | D | 87 338 | ||||||||
2015-05-05 | 3 | VITULLO NICOLE | CLCD | Common Stock | D | 87 338 | ||||||||
2015-05-05 | 3 | VITULLO NICOLE | CLCD | Common Stock | D | 87 338 | ||||||||
2015-05-05 | 3 | VITULLO NICOLE | CLCD | Common Stock | D | 87 338 | ||||||||
2015-05-05 | 3 | VITULLO NICOLE | CLCD | Common Stock | D | 87 338 | ||||||||
2015-05-05 | 3 | VITULLO NICOLE | CLCD | Common Stock | D | 87 338 | ||||||||
2015-05-05 | 3 | VITULLO NICOLE | CLCD | Common Stock | D | 87 338 | ||||||||
2015-05-05 | 3 | PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC | CLCD | Common Stock | I | 11 058 | ||||||||
2015-05-05 | 3 | PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Common Stock | I | 5 532 | ||||||||
2015-05-05 | 3 | PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Common Stock | I | 5 532 | ||||||||
2015-05-05 | 3 | PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC | CLCD | Common Stock | I | 11 058 | ||||||||
2015-05-05 | 3 | PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Common Stock | I | 5 532 | ||||||||
2015-05-05 | 3 | PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC | CLCD | Common Stock | I | 11 058 | ||||||||
2015-05-05 | 3 | PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC | CLCD | Common Stock | I | 11 058 | ||||||||
2015-05-05 | 3 | PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Common Stock | I | 5 532 | ||||||||
2015-05-05 | 3 | PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC | CLCD | Common Stock | I | 11 058 | ||||||||
2015-05-05 | 3 | PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P. | CLCD | Common Stock | I | 5 532 |